Department of Surgery, North Shore University Hospital and Long Island Jewish Medical Center, 350 Community Dr, Manhasset, NY 11030, USA.
Apoptosis. 2011 Nov;16(11):1077-86. doi: 10.1007/s10495-011-0630-0.
Although the cloning and molecular characterization of MFG-E8 was first reported in the early 90s, breakthrough on MFG-E8 research came into light when it was explored as an outstanding factor for phagocytosis of apoptotic cells by professional macrophages in 2002. Since then numerous studies have been performed on MFG-E8 not only to demonstrate the role of phagocytic clearance of apoptotic cells, but also to focus on a wide range of aspects, even emphasizing on a direct link to innate-immune systems. In terms of its role as therapeutic potentials, our group, as well as others, has shown MFG-E8 to be an essential factor in attenuating inflammation and improving prognosis in several animal models of life threatening diseases. Considering these versatile functions of MFG-E8, several in vitro and in vivo studies were embarked on to explore the mechanistic pathways exerted by MFG-E8 during inflammation. With the relevant cumulative findings, herein we reviewed the potential roles of MFG-E8 in pathophysiological conditions by highlighting its plausible signal-transduction mechanisms.
虽然 MFG-E8 的克隆和分子特征最早在 90 年代初被报道,但直到 2002 年,当它被探索为专业巨噬细胞吞噬凋亡细胞的杰出因子时,MFG-E8 的研究才取得突破。从那时起,已经对 MFG-E8 进行了大量研究,不仅证明了吞噬清除凋亡细胞的作用,而且还关注了广泛的方面,甚至强调了与先天免疫系统的直接联系。就其治疗潜力而言,我们的研究小组以及其他研究小组已经表明,MFG-E8 是减轻几种危及生命疾病的动物模型中的炎症和改善预后的重要因素。考虑到 MFG-E8 的这些多功能作用,已经进行了一些体外和体内研究来探索 MFG-E8 在炎症期间发挥的机制途径。有了相关的累积发现,本文通过强调其可能的信号转导机制,综述了 MFG-E8 在病理生理条件下的潜在作用。